Plasma and Lung Tissue Concentrations of Linezolid in Septic Shock Patients
NCT03308227 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 46
Last updated 2017-10-12
Summary
The study measures the plasma and bronchoalveolar lavage fluid concentrations of linezolid in septic shock patients comparing with non-septic shock patients to confirm the impact of septic shock on PK/PD of linezolid.
Conditions
- Septic Shock
Sponsors & Collaborators
-
Cttq
collaborator INDUSTRY -
Southeast University, China
lead OTHER
Principal Investigators
-
Yingzi Yingzi, PHD · Southeast University
Eligibility
- Min Age
- 19 Years
- Max Age
- 75 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2017-10-20
- Primary Completion
- 2018-02-28
- Completion
- 2018-04-30
More Related Trials
-
Evaluation of Predictive Proteic Profile on Mortality in the Acute Phase of Septic Shock in Cancer Patients
NCT00930085 ·Status: COMPLETED ·Phase: NA
-
Vasculopathic Injury and Plasma as Endothelial Rescue in Septic Shock (SHOCK) Trial
NCT03092245 ·Status: COMPLETED ·Phase: PHASE2
-
Early Goal Directed Sedation on Microcirculation in Septic Shock
NCT02612363 ·Status: UNKNOWN ·Phase: PHASE4
-
Evaluation of Droplet Digital PCR Rapid Detection Method and Precise Diagnosis and Treatment for Suspected Sepsis
NCT05190861 ·Status: COMPLETED ·Phase: NA
-
Platelets to Lymphocytes Ratio in Sepsis
NCT05399225 ·Status: UNKNOWN
-
The PK/PD of Deoxycholic Acid Amphotericin B in Invasive Fungal Infection Patients With Sepsis/Septic Shock
NCT05642624 ·Status: COMPLETED
-
Anisodamine Critically Ill SeptIc Shock
NCT02442440 ·Status: COMPLETED ·Phase: PHASE1/PHASE2
-
A Prediction Model of 28-day Mortality in Septic Shock
NCT04915625 ·Status: UNKNOWN
-
The Pharmacokinetics/Pharmacodynamics of High-dose Daptomycin in Patients With Septic Shock
NCT02508350 ·Status: UNKNOWN ·Phase: NA
-
A Multicenter, Randomized, Double-blind, Placebo-controlled Phase II Dose Exploration Clinical Trial Evaluating the Efficacy, Safety, and Pharmacokinetic Characteristics of STC314 Injection Administered Intravenously in Sepsis Patients
NCT06548854 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE2
-
Effects of Terlipressin on Renal Perfusion in Patients With Septic Shock
NCT04948372 ·Status: COMPLETED ·Phase: NA
-
Investigate the Activity of Endotoxin in Severe Sepsis
NCT01957254 ·Status: TERMINATED
-
Comparison of Sensitivity Between Presepsine and Lactate for the Diagnosis of Severe Sepsis.
NCT02300415 ·Status: UNKNOWN
-
Serum Rennin Kinetics Versus Serum Lactate Kinetics as Predictors of Mortality in Septic Shock Patients
NCT05327881 ·Status: UNKNOWN
-
Neutrophils to Lymphocytes and Platelets Ratio, Procalcitonin, and Total Leucocytic Count as Indicators of Prognostic Outcome in Septic Patients in the Intensive Care Unit.
NCT07200817 ·Status: RECRUITING
-
Procalcitonin Monitoring Sepsis Study
NCT01523717 ·Status: COMPLETED
-
Endotoxin in Gram-negative Septic Shock
NCT01602354 ·Status: UNKNOWN
-
Saving Lives by Early Detection and Treatment of Sepsis and Septic Shock by Point of Care Lactate Test in Adults
NCT05108467 ·Status: UNKNOWN
-
Comparison Between the Progostic Value of the Procalcitonin and the Platelet/Total Leukocytic Count Ratio in Sepsis
NCT06991686 ·Status: COMPLETED
-
Prolonged Intravenous Infusion of β-lactam Antibiotics in Early Septic Patients
NCT05024565 ·Status: UNKNOWN ·Phase: NA
-
N\L Ratio Versus L\A Ratio as a Predictor of Morbidity and Mortality in Sepsis and Septic Shock
NCT05825118 ·Status: UNKNOWN
-
Pharmacokinetics of XueBiJing in Patients With Sepsis
NCT03475732 ·Status: COMPLETED ·Phase: NA
-
Lactate Kinetics in Septic Shock
NCT05349370 ·Status: RECRUITING ·Phase: NA
-
Analysis of Differential Proteins and Maternal Influencing Factors of Septic Shock in Neonates
NCT06206590 ·Status: RECRUITING
-
Diagnostic and Prognostic Evaluation of Vasorin During Septic Shock
NCT07203833 ·Status: RECRUITING ·Phase: NA